What is the CanAssist Breast test?

CanAssist Breast is a prognostic test that helps predict the risk of breast cancer recurrence and supports oncologists in personalizing treatment plans.

Who can benefit from the CanAssist Breast test?

It is suitable for patients diagnosed with early-stage, hormone receptor-positive breast cancer to determine their recurrence risk.

How accurate is the CanAssist Breast test?

CanAssist Breast has been validated on South Asian and Caucasian populations, demonstrating high accuracy in predicting recurrence risk.

Clinical Research Validating Breast Cancer Recurrence Risk Tests

Acharya Harihar Post Graduate Institute of Cancer

Events and Conferences

June, 2023

Dr.Manjiri Bakre gave a talk on the CAB test at Acharya Harihar Post Graduate Institute of Cancer, Bhubaneswar

View

Cancer Medicine

Scientific Publication by OncoStem

May, 2023

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment

View

Breast Cancer Research

Scientific Publication by OncoStem

April, 2023

Ten-year distant-recurrence risk prediction in breast cancer by CanAssist Breast (CAB] in Dutch sub-cohort of the randomized TEAM trial

View

Indian Journal of Medical and Paediatric Oncology

Scientific Publication by Renowned Oncologists Worldwide

April, 2023

Ajay Bapna et al: Risk Stratification of Early Breast Cancer (HR+/HER 2-) by CanAssist Breast and Its Corelation with Other Online Prognostic Tools: Experience from a Single Center

View

Advisory Meeting, Ahmedabad

Events and Conferences

April, 2023

Dr. Chirag Desai presented data on the CAB test at an Advisory Meeting, Ahmedabad

View

ABSI Midcon

Events and Conferences

March, 2023

Dr. S. P. Somashekar shared insights about the CAB test at ABSI Midcon 2023, which was held in Patna

View

28th AIPNA - ICP International CME

Events and Conferences

February, 2023

Dr. B. A. Savitha showcased the CAB test at the 28th AIPNA - ICP International CME

View

Scientific Publications